↓ Skip to main content

A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell…

Overview of attention for article published in Clinical Cancer Research, August 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

policy
2 policy sources
twitter
12 X users
patent
3 patents

Citations

dimensions_citation
140 Dimensions

Readers on

mendeley
127 Mendeley